Evidence map›Paper›PMID 32969543›Full record

ArticleTraffic (Copenhagen, Denmark)2020

Phosphorylation of Rab GTPases in the regulation of membrane trafficking.

Dieter Waschbüsch, Amir R Khan

Open access · hybridAbstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. The Procaine-Based ProcClusterInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Dieter WaschbüschSchool of Biochemistry and Immunology, Trinity College, Dublin, Ireland.
Amir R KhanSchool of Biochemistry and Immunology, Trinity College, Dublin, Ireland.ORCID 0000-0003-1176-6952
Boston Children's Hospital · USTrinity College Dublin · IE

Funding

Program in Cellular and Molecular Medicine Harvard Medical School
6 · The paper itself

Abstract

Rab GTPases are master regulators of membrane trafficking in eukaryotic cells. Phosphorylation of Rab GTPases was characterized in the 1990s and there have been intermittent reports of its relevance to Rab functions. Phosphorylation as a regulatory mechanism has gained prominence through the identification of Rabs as physiological substrates of leucine-rich repeat kinase 2 (LRRK2). LRRK2 is a Ser/Thr kinase that is associated with inherited and sporadic forms of Parkinson disease. In recent years, numerous kinases and their associated signaling pathways have been identified that lead to phosphorylation of Rabs. These emerging studies suggest that serine/threonine and tyrosine phosphorylation of Rabs may be a widespread and under-appreciated mechanism for controlling their membrane trafficking functions. Here we survey current knowledge of Rab phosphorylation and discuss models for how this post-translational mechanism exerts control of membrane trafficking.

Indexed as

Parkinson Diseaserab GTP-Binding ProteinsHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2PhosphorylationProtein TransportLeucine-Rich Repeat Serine-Threonine Protein Kinase-2rab GTP-Binding ProteinseffectorGDP/GTP dissociation inhibitorGDP/GTP exchange factorGTPase activating proteinmembrane traffickingphosphorylationRab GTPaseSer/Thr kinasetyrosine kinase

Identifiers

PMID32969543
PMCPMC7756361
OpenAlexW3089277146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.